These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 7539763)
1. Purification and characterization of endogenous peptides extracted from HLA-DR isolated from the spleen of a patient with rheumatoid arthritis. Gordon RD; Young JA; Rayner S; Luke RW; Crowther ML; Wordsworth P; Bell J; Hassall G; Evans J; Hinchliffe SA Eur J Immunol; 1995 May; 25(5):1473-6. PubMed ID: 7539763 [TBL] [Abstract][Full Text] [Related]
2. Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules. Fridkis-Hareli M; Neveu JM; Robinson RA; Lane WS; Gauthier L; Wucherpfennig KW; Sela M; Strominger JL J Immunol; 1999 Apr; 162(8):4697-704. PubMed ID: 10202010 [TBL] [Abstract][Full Text] [Related]
3. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles. Kirschmann DA; Duffin KL; Smith CE; Welply JK; Howard SC; Schwartz BD; Woulfe SL J Immunol; 1995 Dec; 155(12):5655-62. PubMed ID: 7499850 [TBL] [Abstract][Full Text] [Related]
4. T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex. Kosmopoulou A; Vlassi M; Stavrakoudis A; Sakarellos C; Sakarellos-Daitsiotis M J Comput Chem; 2006 Jul; 27(9):1033-44. PubMed ID: 16639700 [TBL] [Abstract][Full Text] [Related]
5. DR4Dw4/DR53 molecules contain a peptide from the autoantigen calreticulin. Verreck FA; Elferink D; Vermeulen CJ; Amons R; Breedveld F; de Vries RR; Koning F Tissue Antigens; 1995 Apr; 45(4):270-5. PubMed ID: 7638864 [TBL] [Abstract][Full Text] [Related]
6. Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection. Godkin AJ; Davenport MP; Willis A; Jewell DP; Hill AV J Immunol; 1998 Jul; 161(2):850-8. PubMed ID: 9670963 [TBL] [Abstract][Full Text] [Related]
7. Characterization of T cell epitopes restricted by HLA-DP9 in streptococcal M12 protein. Dong RP; Kamikawaji N; Toida N; Fujita Y; Kimura A; Sasazuki T J Immunol; 1995 May; 154(9):4536-45. PubMed ID: 7536773 [TBL] [Abstract][Full Text] [Related]
8. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413 [TBL] [Abstract][Full Text] [Related]
9. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674 [TBL] [Abstract][Full Text] [Related]
10. Molecular interactions between transfected human TCR, immunodominant myelin basic protein peptide 152-165, and HLA-DR13. Hastings AE; Hurley CK; Robinson ED; Salerno K; Hernandez E; Richert JR J Immunol; 1996 Oct; 157(8):3460-71. PubMed ID: 8871645 [TBL] [Abstract][Full Text] [Related]
11. 70-kDa heat shock proteins: specific interactions with HLA-DR molecules and their peptide fragments. Haug M; Schepp CP; Kalbacher H; Dannecker GE; Holzer U Eur J Immunol; 2007 Apr; 37(4):1053-63. PubMed ID: 17357109 [TBL] [Abstract][Full Text] [Related]
12. Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants. Monji T; McCormack AL; Yates JR; Pious D J Immunol; 1994 Nov; 153(10):4468-77. PubMed ID: 7525705 [TBL] [Abstract][Full Text] [Related]
13. Characterization of B- and T-cell responses and HLA-DR4 binding motifs of the latex allergen Hev b 6.01 (prohevein) and its post-transcriptionally formed proteins Hev b 6.02 and Hev b 6.03. Raulf-Heimsoth M; Rozynek P; Brüning T; Rihs HP Allergy; 2004 Jul; 59(7):724-33. PubMed ID: 15180759 [TBL] [Abstract][Full Text] [Related]
14. HLA class I self peptides isolated from a T-cell leukemia reveal the allele-specific motif of HLA-B38. Colovai AI; Suciu-Foca N; Baiulescu GE; Harris PE Tissue Antigens; 1994 Aug; 44(2):65-72. PubMed ID: 7817380 [TBL] [Abstract][Full Text] [Related]
16. Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis. Diab BY; Lambert NC; L'Faqihi FE; Loubet-Lescoulié P; de Préval C; Coppin H Immunogenetics; 1999 Jan; 49(1):36-44. PubMed ID: 9811967 [TBL] [Abstract][Full Text] [Related]
17. Possible association of non-binding of HSP70 to HLA-DRB1 peptide sequences and protection from rheumatoid arthritis. Maier JT; Haug M; Föll JL; Beck H; Kalbacher H; Rammensee HG; Dannecker GE Immunogenetics; 2002 May; 54(2):67-73. PubMed ID: 12037598 [TBL] [Abstract][Full Text] [Related]
18. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules. Manfredi AA; Yuen MH; Moiola L; Protti MP; Conti-Tronconi BM J Immunol; 1994 Apr; 152(8):4165-74. PubMed ID: 7511671 [TBL] [Abstract][Full Text] [Related]